Crossref
What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?
Oncology in Clinical Practice · 15.01.2026 · 22
DOI: 10.5603/ocp.112556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Sylwia Dębska-Szmich und 1 weiteren Autor:innen.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dębska-Szmich, S., & Potemski, P. (2026). What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.112556
Vancouver
Dębska-Szmich S, Potemski P. What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.112556
BibTeX
@article{DbskaSzmich2026,
author = {Dębska-Szmich, Sylwia and Potemski, Piotr},
title = {What perioperative treatment should be administered to breast cancer patients carrying a BRCA mutation?},
journal = {Oncology in Clinical Practice},
year = {2026},
volume = {22},
number = {0},
doi = {10.5603/ocp.112556}
}
EUVIMED